Name | Number of supported studies | Average coverage | |
---|---|---|---|
natural killer cell | 34 studies | 43% ± 21% | |
macrophage | 31 studies | 49% ± 18% | |
classical monocyte | 18 studies | 37% ± 21% | |
monocyte | 15 studies | 42% ± 15% | |
CD16-positive, CD56-dim natural killer cell, human | 15 studies | 34% ± 15% | |
conventional dendritic cell | 14 studies | 36% ± 13% | |
mature NK T cell | 13 studies | 29% ± 11% | |
non-classical monocyte | 11 studies | 37% ± 19% | |
CD8-positive, alpha-beta T cell | 10 studies | 25% ± 9% | |
CD16-negative, CD56-bright natural killer cell, human | 9 studies | 47% ± 20% | |
myeloid cell | 7 studies | 56% ± 18% | |
dendritic cell | 6 studies | 36% ± 12% | |
neutrophil | 6 studies | 52% ± 25% | |
leukocyte | 6 studies | 32% ± 6% | |
gamma-delta T cell | 6 studies | 24% ± 7% | |
effector CD8-positive, alpha-beta T cell | 4 studies | 33% ± 13% | |
microglial cell | 4 studies | 49% ± 34% | |
CD8-positive, alpha-beta memory T cell | 4 studies | 25% ± 11% | |
T cell | 3 studies | 28% ± 8% | |
mononuclear phagocyte | 3 studies | 34% ± 12% | |
innate lymphoid cell | 3 studies | 23% ± 8% | |
inflammatory macrophage | 3 studies | 55% ± 24% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 356.43 | 571 / 578 | 77% | 2.87 | 895 / 1155 |
breast | 68% | 63.69 | 314 / 459 | 72% | 2.46 | 804 / 1118 |
liver | 84% | 79.89 | 190 / 226 | 46% | 1.15 | 186 / 406 |
kidney | 57% | 29.87 | 51 / 89 | 66% | 2.61 | 592 / 901 |
intestine | 47% | 25.00 | 454 / 966 | 69% | 3.30 | 364 / 527 |
adrenal gland | 62% | 53.59 | 159 / 258 | 54% | 2.87 | 125 / 230 |
brain | 28% | 27.12 | 745 / 2642 | 85% | 11.79 | 600 / 705 |
bladder | 48% | 27.95 | 10 / 21 | 59% | 3.14 | 296 / 504 |
stomach | 38% | 22.11 | 138 / 359 | 65% | 2.92 | 187 / 286 |
thymus | 44% | 22.31 | 287 / 653 | 59% | 1.68 | 359 / 605 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.52 | 29 / 29 |
spleen | 100% | 623.92 | 241 / 241 | 0% | 0 | 0 / 0 |
ovary | 26% | 9.81 | 46 / 180 | 68% | 2.23 | 292 / 430 |
uterus | 28% | 11.28 | 47 / 170 | 66% | 2.44 | 301 / 459 |
skin | 13% | 4.45 | 229 / 1809 | 72% | 3.35 | 342 / 472 |
peripheral blood | 84% | 2015.04 | 780 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 82% | 3.46 | 37 / 45 |
adipose | 80% | 114.10 | 967 / 1204 | 0% | 0 | 0 / 0 |
prostate | 40% | 21.34 | 98 / 245 | 40% | 0.92 | 200 / 502 |
pancreas | 13% | 4.65 | 41 / 328 | 58% | 1.63 | 104 / 178 |
esophagus | 13% | 4.68 | 190 / 1445 | 46% | 1.30 | 84 / 183 |
blood vessel | 54% | 67.14 | 720 / 1335 | 0% | 0 | 0 / 0 |
heart | 36% | 17.09 | 308 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 20% | 0.52 | 16 / 80 |
muscle | 5% | 2.06 | 40 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0043615 | Biological process | astrocyte cell migration |
GO_0070723 | Biological process | response to cholesterol |
GO_1903980 | Biological process | positive regulation of microglial cell activation |
GO_1904141 | Biological process | positive regulation of microglial cell migration |
GO_0006954 | Biological process | inflammatory response |
GO_0050850 | Biological process | positive regulation of calcium-mediated signaling |
GO_0019722 | Biological process | calcium-mediated signaling |
GO_0043547 | Biological process | positive regulation of GTPase activity |
GO_0000165 | Biological process | MAPK cascade |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0050918 | Biological process | positive chemotaxis |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0043308 | Biological process | eosinophil degranulation |
GO_0043922 | Biological process | negative regulation by host of viral transcription |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0030593 | Biological process | neutrophil chemotaxis |
GO_0050795 | Biological process | regulation of behavior |
GO_0051930 | Biological process | regulation of sensory perception of pain |
GO_0071347 | Biological process | cellular response to interleukin-1 |
GO_0006935 | Biological process | chemotaxis |
GO_0006874 | Biological process | intracellular calcium ion homeostasis |
GO_0007010 | Biological process | cytoskeleton organization |
GO_0007267 | Biological process | cell-cell signaling |
GO_0043525 | Biological process | positive regulation of neuron apoptotic process |
GO_0090280 | Biological process | positive regulation of calcium ion import |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_0001775 | Biological process | cell activation |
GO_0070098 | Biological process | chemokine-mediated signaling pathway |
GO_0006887 | Biological process | exocytosis |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0048247 | Biological process | lymphocyte chemotaxis |
GO_0030502 | Biological process | negative regulation of bone mineralization |
GO_2000503 | Biological process | positive regulation of natural killer cell chemotaxis |
GO_0048245 | Biological process | eosinophil chemotaxis |
GO_0051928 | Biological process | positive regulation of calcium ion transport |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO_0008360 | Biological process | regulation of cell shape |
GO_0071621 | Biological process | granulocyte chemotaxis |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_0009636 | Biological process | response to toxic substance |
GO_0002548 | Biological process | monocyte chemotaxis |
GO_0010818 | Biological process | T cell chemotaxis |
GO_0014808 | Biological process | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0006816 | Biological process | calcium ion transport |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0023052 | Biological process | signaling |
GO_0048246 | Biological process | macrophage chemotaxis |
GO_0071346 | Biological process | cellular response to type II interferon |
GO_0045671 | Biological process | negative regulation of osteoclast differentiation |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0016004 | Molecular function | phospholipase activator activity |
GO_0031726 | Molecular function | CCR1 chemokine receptor binding |
GO_0031730 | Molecular function | CCR5 chemokine receptor binding |
GO_0008009 | Molecular function | chemokine activity |
GO_0048020 | Molecular function | CCR chemokine receptor binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0004672 | Molecular function | protein kinase activity |
GO_0042056 | Molecular function | chemoattractant activity |
GO_0016301 | Molecular function | kinase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CCL3 |
Protein name | C-C motif chemokine C-C motif chemokine 3 (G0/G1 switch regulatory protein 19-1) (Macrophage inflammatory protein 1-alpha) (MIP-1-alpha) (PAT 464.1) (SIS-beta) (Small-inducible cytokine A3) (Tonsillar lymphocyte LD78 alpha protein) [Cleaved into: MIP-1-alpha(4-69) (LD78-alpha(4-69))] |
Synonyms | SCYA3 G0S19-1 MIP1A hCG_1749202 |
Description | FUNCTION: Monokine with inflammatory and chemokinetic properties. Binds to CCR1, CCR4 and CCR5. One of the major HIV-suppressive factors produced by CD8+ T-cells. Recombinant MIP-1-alpha induces a dose-dependent inhibition of different strains of HIV-1, HIV-2, and simian immunodeficiency virus (SIV). . |
Accessions | P10147 ENST00000616221.2 A0N0R1 ENST00000613396.2 ENST00000613922.2 |